Ilaria Izzo

Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz

Emanuele Focà, Davide Motta, Marco Borderi et al. · BMC Infectious Diseases · 2012 · 41 citations · Full text

Medicine, Pharmacotherapy, Bone Metabolism +16

A Randomized, Pilot Trial to Evaluate Glomerular Filtration Rate by Creatinine or Cystatin C in Naive HIV-Infected Patients After Tenofovir/Emtricitabine in Combination With Atazanavir/Ritonavir or Efavirenz

Laura Albini, Bruno Mario Cesana, Davide Motta et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2011 · 41 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +17

Emergence of Exhausted B Cells in Asymptomatic HIV-1-Infected Patients Naïve for HAART is Related to Reduced Immune Surveillance

Manuela Fogli, Carlo Torti, Fabio Malacarne et al. · Clinical and Developmental Immunology · 2012 · 40 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Colitis during new direct-acting antiviral agents (DAAs) therapy with sofosbuvir, simeprevir and ribavirin for genotype 1b hepatitis C

Ilaria Izzo, Paola Zanotti, Claudia Chirico et al. · Infection · 2016 · 40 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Increase in Standard Cholesterol and Large HDL Particle Subclasses in Antiretroviral-Naïve Patients Prescribed Efavirenz Compared to Atazanavir/Ritonavir

D Gotti, Bruno Mario Cesana, Laura Albini et al. · HIV Clinical Trials · 2012 · 26 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17